Illumina's CEO Promises Growth By 2027, Because Patience Is A Strategy
Jacob Thaysen, Illumina's fearless captain navigating the turbulent biotech seas, insists they're still on course for a modest 'high single-digit revenue growth' by the distant shores of 2027. Despite unexpected headwinds—likely a fancy euphemism for market chaos, supply chain mayhem, or maybe his coffee machine breaking—the CEO remains optimistic. Illumina, known for turning DNA into some kind of money magic, apparently believes five more years of slow growth is an acceptable life strategy. It's 2024, investors might just want to pop some popcorn and enjoy the slowest rollercoaster ride in corporate history.
Share the Story
(1 of 3)Illumina’s CEO is basically telling investors, 'Hang tight, it’s a glacier-speed race to glory by 2027,' because nothing screams excitement like three years to reach what a startup might pull off in six months.
Who needs quarterly fireworks when you can watch Illumina’s revenue growth crawl at a snail’s pace through 2027? CEO must think investors love suspenseful slow burns.
Illumina’s strategy: convince Wall Street that waiting for 'high single-digit growth' five years from now is a thrilling binge-watch, not a patience test.
Source: Statnews | Published: 8/26/2025 | Author: Jonathan Wosen
More Articles in Business
OpenAI CEO’s $27M Mansion Molotoved Amid AI Lab Soap Opera
Sydney Sweeney's $1M Flop, Trump-Approved Jeans & Bathwater Soap Fiasco
Digital Nomad Trapped in Lisbon FOMO, Ends Up BFF Ghosted
FedEx, UPS, and DHL Embark on Epic Refund Quest, Customers Await Payback Like Lottery Winners
Tim Cook Steps Down, Apple Picks John Ternus Because 'Risk-Taking' Is Overrated
Apple Hands CEO Reins to Hardware Guy Who Says 'Logistics Are Cute, Look at This Widget'
American Grads Panic, Prefer DoorDash Over Dream Jobs, Blame AI(ish)
Amazon Instructs Vendors to Play Monopoly, Then Calls It Lawful Commerce
